A new, highly potent experimental drug named Retatrutide, often dubbed the 'Godzilla' of weight loss jabs and 'triple G' due to its mechanism, has become the subject of urgent warnings amid a concerning surge in black market demand. Early clinical trials of Retatrutide, manufactured by Eli Lilly,suggest it can help individuals shed nearly a quarter of their body weight in under a year, demonstrating almost twice the effectiveness of other popular slimming injections likeOzempic.

Unlike other treatments, Retatrutide targets three hormones involved in eating and weight regulation (GLP, GIP, and glucagon), not only suppressing appetite but also significantly speeding up metabolism. Initial phase II studies showed participants losing an average of 24 to 28.5 percent of their body weight in 48 weeks, with some even dropping almost a third in eight months, surpassing the results seen with tirzepatide (Mounjaro, up to 21 percent) and semaglutide (Ozempic/Wegovy, up to 15 percent).

Despite its striking efficacy, Retatrutide is still in Phase 3 clinical trials, with results not anticipated until 2026 and potential market approval not before late 2026 or 2027. However, this has not deterred social media users from claiming to have sourced the drug on the black market, boasting significant weight loss in mere months. A substantial spike in online searches for 'where to inject Retatrutide' in the UK followed Eli Lilly's announcement of increased costs for its approved weight loss jab, Mounjaro.

Photo Credit: The Sun

Health experts, along with authorities like the MHRA, FDA, andEli Lillyitself, have issued stern warnings against acquiring Retatrutide from unapproved sources. Danielle Brightman, clinical director at Numan, emphasized the 'incredibly risky' nature of the black market, stating that such products are often unregulated, with no guarantee of dose, purity, or even the active ingredient. Using them can expose individuals to serious side effects, contamination, and long-term harm. Instances of black market versions of similar drugs being laced with substances like rat poison and cement have been reported, and dangerous 'DIY' injection kits have been intercepted. Lilly itself warns that any product falsely representing itself as an investigational product not yet approved may expose patients to potentially serious health risks.

Beyond health dangers, possessing unlicensed medication like Retatrutide is illegal under UK law, potentially leading to fines and up to two years in prison. Social media platforms, including Reddit, TikTok, YouTube, and Instagram, have been instrumental in the proliferation of black market sales, with users openly advertising and seeking the drug. While TikTok has started banning videos promoting Retatrutide, the informal network persists.

The dangers are starkly illustrated by personal accounts. Erin, a single mother of three, resorted to sourcing Retatrutide from a beautician friend after failing to achieve weight loss with prescribed semaglutide and Mounjaro. Despite concerns about its unapproved status, she felt reassured by trusting her friend. After her first injection, Erin experienced severe cramps and a bad headache, though these subsided. She noted reduced appetite and cravings but also a waning effect by day four to six.

While she reported an initial weight loss of 6lbs in a month, her method involved mixing the powdered drug with water by hand, a practice widely discouraged by experts, and relying on someone else to administer the injection due to needle phobia. Erin's situation highlights the desperate measures individuals take, putting themselves at risk for unverified products.

Photo Credit: The Sun

Even with genuine Retatrutide,the rapid and significant weight loss observed in trials brings its own set of medical concerns, including malnutrition, loss of lean muscle, gallstones, and kidney problems—risks also associated with bariatric surgery. While Retatrutide appears to preserve more muscle than rival jabs, doctors stress the need for much more data on its long-term safety.

Reports from clinical trials indicate that some participants lost so much weight so quickly that researchers had to lower doses or instruct them to increase calorie intake, underlining the need for careful medical control. Experts continue to urge the public to only obtain medicines from licensed pharmacies with valid prescriptions, emphasizing that unless participating in an official clinical trial, any Retatrutide obtained is unlikely to be genuine and could be highly dangerous.